[go: up one dir, main page]

PE20030948A1 - Proceso para la preparacion de una suspension esteril de particulas de dipropionato de beclometasona para administracion por inhalacion - Google Patents

Proceso para la preparacion de una suspension esteril de particulas de dipropionato de beclometasona para administracion por inhalacion

Info

Publication number
PE20030948A1
PE20030948A1 PE2003000389A PE2003000389A PE20030948A1 PE 20030948 A1 PE20030948 A1 PE 20030948A1 PE 2003000389 A PE2003000389 A PE 2003000389A PE 2003000389 A PE2003000389 A PE 2003000389A PE 20030948 A1 PE20030948 A1 PE 20030948A1
Authority
PE
Peru
Prior art keywords
turbine
beclometasone dipropionate
istiling
corticosteroid
suspension
Prior art date
Application number
PE2003000389A
Other languages
English (en)
Inventor
Barbara Sambuco
Daniele Pirrotta
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of PE20030948A1 publication Critical patent/PE20030948A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

QUE COMPRENDE: 1)AGREGAR UNO O MAS INGREDIENTES ACTIVOS, TAL COMO UN CORTICOSTEROIDE, BAJO LA FORMA DE UN POLVO ESTERIL MICRONIZADO, A UNA SOLUCION ACUOSA QUE CONSTITUYE EL VEHICULO, LA CUAL CONTIENE ADITIVOS O EXCIPIENTES SELECCIONADOS ENTRE AGENTES HUMECTANTES, ESTABILIZADORES, ISOTONICOS Y/O AMORTIGUADORES, EN UN TURBO EMULSIFICADOR EQUIPADO CON UNA TURBINA DE ALTO PODER Y CONECTADO A UNA TOLVA DE CARGA, INTRODUCIENDO LOS INGREDIENTES ACTIVOS A TRAVES DE LA TURBINA DESPUES DE APLICAR EL VACIO; 2)HOMOGENEIZAR EL INGREDIENTE ACTIVO EN LA SUSPENSION, AUN AL VACIO, USANDO EL SISTEMA DE TURBINA, A UNA VELOCIDAD ENTRE 750 rpm Y 4000 rpm DURANTE 10 min A 60 min; Y, 3)DISTRIBUIR LA SUSPENSION OBTENIDA DE ESTE MODO EN RECIPIENTES ADECUADOS DE DOSIS INDIVIDUALES . DONDE, EL PROCESO SE REALIZA BAJO CONDICIONES ESTERILES, AGREGANDO UN CORTICOSTEROIDE, TAL COMO DIPROPIONATO DE BECLOMETASONA, ESTERILIZADO POR IRRADIACION O CALENTAMIENTO. SE REFIERE TAMBIEN A FORMULACIONES FARMACEUTICAS QUE SE UTILIZAN PARA NEBULIZACION, EN EL TRATAMIENTO DE ENFERMEDADES PULMONARES, QUE CONSTAN DE DOSIS UNITARIAS QUE CONTIENEN SUSPENSIONES ACUOSAS OBTENIDAS EN EL PROCESO ANTES DESCRITO
PE2003000389A 2002-04-17 2003-04-16 Proceso para la preparacion de una suspension esteril de particulas de dipropionato de beclometasona para administracion por inhalacion PE20030948A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000808A ITMI20020808A1 (it) 2002-04-17 2002-04-17 Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione

Publications (1)

Publication Number Publication Date
PE20030948A1 true PE20030948A1 (es) 2004-01-19

Family

ID=11449718

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000389A PE20030948A1 (es) 2002-04-17 2003-04-16 Proceso para la preparacion de una suspension esteril de particulas de dipropionato de beclometasona para administracion por inhalacion

Country Status (25)

Country Link
US (1) US7541021B2 (es)
EP (1) EP1494647B1 (es)
CN (1) CN1292733C (es)
AR (1) AR039317A1 (es)
AT (1) ATE338539T1 (es)
AU (1) AU2003227627A1 (es)
BR (1) BRPI0304821B8 (es)
CA (1) CA2481520C (es)
CY (1) CY1105800T1 (es)
DE (1) DE60308164T2 (es)
DK (1) DK1494647T3 (es)
EA (1) EA007629B1 (es)
ES (1) ES2272987T3 (es)
HK (1) HK1079986B (es)
HR (1) HRP20040964A2 (es)
IT (1) ITMI20020808A1 (es)
MA (1) MA27194A1 (es)
MX (1) MXPA04010117A (es)
PE (1) PE20030948A1 (es)
PL (1) PL207863B1 (es)
PT (1) PT1494647E (es)
SI (1) SI1494647T1 (es)
UA (1) UA79453C2 (es)
WO (1) WO2003086347A1 (es)
ZA (1) ZA200408319B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004052374A1 (en) * 2002-12-12 2004-06-24 Altana Pharma Ag Combination medicament
PL1670482T5 (pl) * 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
CA2543242C (en) * 2003-10-23 2015-04-14 Otsuka Pharmaceutical Co., Ltd. Controlled release sterile freeze-dried aripiprazole formulation and injectable formulation thereof
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
EP1740188A1 (en) * 2004-04-20 2007-01-10 Altana Pharma AG Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
GB0425266D0 (en) 2004-11-16 2004-12-15 Norton Healthcare Ltd Pharmaceutical manufacturing process
EP1683514B1 (en) 2005-01-20 2012-05-23 Eratech S.r.l. Process for the preparation of concentrated suspensions of drugs and kit thereof
US20070148100A1 (en) * 2005-09-15 2007-06-28 Elan Pharma International, Limited Nanoparticulate aripiprazole formulations
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
JP2009526619A (ja) * 2006-02-15 2009-07-23 ティカ レーケメデル アーベー 質量減量を伴うコルチコステロイドの滅菌
PT2170348T (pt) * 2007-06-22 2016-11-02 Dompé Farm S P A Comprimidos efervescentes para utilização por via inalatória
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
MX2010001311A (es) * 2007-07-31 2010-04-21 Otsuka Pharma Co Ltd Metodo para producir una suspensi?n de aripiprazol y formulacion liofilizada.
CN102657659A (zh) * 2010-11-23 2012-09-12 天津金耀集团有限公司 皮肤用含有辅料的丙酸氟替卡松与含有辅料的水的透皮吸收药物
CN102475708A (zh) * 2010-11-23 2012-05-30 天津金耀集团有限公司 丙酸氟替卡松和含辅料的水构成的治疗皮肤病的分离式水混悬剂药物
HUE030016T2 (en) 2011-05-03 2017-04-28 Chiesi Farm Spa An improved suspension beclomethasone dipropionate formulation for inhalation administration
CN103505412A (zh) * 2012-06-26 2014-01-15 上海臣邦医药科技有限公司 一种吸入用丙酸氟替卡松混悬液的制备方法
WO2022098321A1 (en) * 2020-11-09 2022-05-12 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilised suspensions for the administration by inhalation
WO2022231533A1 (en) * 2021-04-29 2022-11-03 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilized suspensions for the inhalation by nebulization
WO2022231531A1 (en) * 2021-04-29 2022-11-03 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilized suspensions for the inhalation by nebulization
WO2023022672A2 (en) * 2021-08-18 2023-02-23 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of homogeneous suspensions for the inhalation by nebulization
WO2024180569A1 (en) * 2023-03-01 2024-09-06 Ajaykumar Balraj Kanduri A synergistic aqueous nebulization suspension for management of infectious respiratory disorders and process of preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303692B1 (it) * 1998-11-03 2001-02-23 Chiesi Farma Spa Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.
ITMI20022674A1 (it) * 2002-12-18 2004-06-19 Chiesi Farma Spa Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.

Also Published As

Publication number Publication date
ATE338539T1 (de) 2006-09-15
US7541021B2 (en) 2009-06-02
EA007629B1 (ru) 2006-12-29
EA200401209A1 (ru) 2005-10-27
CY1105800T1 (el) 2011-02-02
PL373331A1 (en) 2005-08-22
CA2481520A1 (en) 2003-10-23
DK1494647T3 (da) 2007-01-15
ES2272987T3 (es) 2007-05-01
ZA200408319B (en) 2006-03-29
BRPI0304821B8 (pt) 2021-05-25
US20050175546A1 (en) 2005-08-11
BR0304821A (pt) 2004-06-15
EP1494647B1 (en) 2006-09-06
CA2481520C (en) 2011-02-22
HRP20040964A2 (en) 2005-02-28
CN1292733C (zh) 2007-01-03
CN1652748A (zh) 2005-08-10
ITMI20020808A0 (it) 2002-04-17
DE60308164D1 (de) 2006-10-19
AR039317A1 (es) 2005-02-16
DE60308164T2 (de) 2007-08-09
HK1079986B (zh) 2007-05-11
EP1494647A1 (en) 2005-01-12
ITMI20020808A1 (it) 2003-10-17
PT1494647E (pt) 2007-01-31
MXPA04010117A (es) 2004-12-13
HK1079986A1 (en) 2006-04-21
AU2003227627A1 (en) 2003-10-27
BRPI0304821B1 (pt) 2018-11-06
UA79453C2 (en) 2007-06-25
SI1494647T1 (sl) 2007-02-28
PL207863B1 (pl) 2011-02-28
WO2003086347A1 (en) 2003-10-23
MA27194A1 (fr) 2005-01-03

Similar Documents

Publication Publication Date Title
PE20030948A1 (es) Proceso para la preparacion de una suspension esteril de particulas de dipropionato de beclometasona para administracion por inhalacion
US8129364B2 (en) Formulations and methods for treating rhinosinusitis
TR200101209T2 (tr) Teneffüs yoluyla uygulanan ilaç parçacıklarının süspansiyonlarının hazırlanması için bir işlem
EP1613280B1 (en) Nasal pharmaceutical formulations and methods of using the same
US20080058295A1 (en) Nasal pharmaceutical formulations and methods of using the same
ES2606541T3 (es) Proteína CC10 humana recombinante para el tratamiento de la gripe
CO6220945A2 (es) Uso de una composicion que comprende formoterol y dipropianato de beclometasona para la prevencion y/o tratamiento de una exacerbacion de asma
US6187765B1 (en) Mometasone furoate suspensions for nebulization
JP2025506543A (ja) エンシフェントリンを含む無菌液体医薬組成物の滅菌プロセス
EP1033991B1 (en) Mometasone furoate suspensions for nebulization
JP2008531467A5 (es)
RU2005130637A (ru) Стерилизация лекарственных частиц беклометазона для доставки через легкие
AR086248A1 (es) Formulacion en forma de suspension mejorada de un corticosteroide que puede administrarse por inhalacion
JP2008538580A (ja) 活性ビタミンd化合物またはその模倣体による、化学療法または放射線療法と関連する肺疾患の治療、予防、および改善
US11903925B2 (en) Compositions for preventing and treating pulmonary injury due to ionizing radiation or cytotoxic drugs
AU2004229149B2 (en) Formulations and methods for treating rhinosinusitis
CN120678941A (zh) 一种脂肪脱细胞基质作为药物缓释载体材料的应用
AR096878A1 (es) FORMULACIÓN EN POLVO SECO QUE COMPRENDE UN ANTICOLINÉRGICO, UN CORTICOSTEROIDE Y UN b-ADRENÉRGICO PARA ADMINISTRAR POR INHALACIÓN
JP2015163614A5 (es)
Selvam et al. Design, Synthesis and West Nile Protease Inhibitory Activity of Novel Isatin Derivatives
JP2013049687A5 (es)
Young et al. Anesthetic effects of medetomidine-tiletamine/zolazepam combination in green iguanas (Iguana iguana)

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed